Rocket Lab Corporation (NasdaqCM : RKLB) entered into a non-binding term sheet to acquire Mynaric AG (XTRA:M0YN) for $150 million on March 10, 2025. Rocket Lab USA, Inc. entered into a Stock Purchase Agreement Mynaric AG on September 25, 2025. As part of the acquisition, Rocket Lab would acquire 100% of the outstanding equity interests of Mynaric and initial purchase price is expected to be $75 million payable in either cash or shares of common stock of Rocket Lab, at Rocket Lab?s option, with the potential for additional earn-out consideration based on future revenue targets of the Mynaric business of up to an additional $75 million in shares of Rocket Lab common stock or cash, at Rocket Lab?s option. The initial closing purchase price will also be increased (and the potential earnout consideration correspondingly decreased) to the extent of any additional cash investment by the Lenders or their affiliates in Mynaric after completion of the StaRUG Restructuring and before the closing of the potential acquisition. If Rocket Lab USA, Inc chooses to issue cash consideration, then the proceeds from the offering will be used to fund the acquisition.

The transaction is subject to receipt of certain governmental approvals, following the completion of Mynaric?s previously announced and pending StaRUG restructuring proceedings under German law, the completion of which would result in certain outstanding debt held by the Lenders converting into 100% of the equity of Mynaric, subject to customary due diligence and signing of definitive agreement. Germany?s Federal Ministry for Economic Affairs and Energy approved the transaction.

Rocket Lab Corporation (NasdaqCM : RKLB) completed the acquisition of Mynaric AG (XTRA:M0YN) for approximately $160 million on April 14, 2026. The consideration consists of a nominal cash payment and 2,277,002 shares of the Rocket Lab Corporation's Common Stock, of which 109,943 shares of Rocket Lab Corporation Common Stock were deposited in an indemnity escrow. The closing consideration was primary based on a base purchase price of $75 million plus additional investments made by the Sellers in Mynaric prior to closing with a corresponding reduction in the attainable earnout consideration under the Purchase Agreement, including amounts to be held in escrow in connection therewith. Subject to post-closing purchase price adjustments, the Sellers are no longer eligible for further earnout payments.